Atlas Venture Opportunity Fund II, L.P. [Rocket]

Transactions

Atlas Venture Opportunity Fund II, L.P.

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
12/12/2022	Dyne Therapeutics, Inc.		Purchase	Common Stock	934.6k	$10.70	$10M		12/12/2022
06/17/2022	Day One Biopharmaceuticals, Inc.		Purchase	Common Stock	766.7k	$15.00	$11.5M		06/17/2022